- Home
- Life Sciences
- Pharmaceutical
- Pharmaceutical Analysis & Statistics in Europe Countries, May 2013
Talk to Alison
00 1 718 618 48 97
Search inside this page
Publishers
- All
- Espicom Business Intelligence
All regions
- All
- Europe
- Austria (3)
- Belgium (3)
- Bulgaria (2)
- Czech Republic (2)
- Denmark (2)
- Finland (1)
- France (6)
- Germany (12)
- Hungary (2)
- Iceland (1)
- Ireland (4)
- Italy (3)
- Latvia (1)
- Lithuania (1)
- Netherlands (3)
- Norway (2)
- Poland (1)
- Portugal (1)
- Romania (3)
- Russian Federation (5)
- Serbia and Montenegro (1)
- Slovakia (slovak Republic) (2)
- Slovenia (1)
- Spain (5)
- Sweden (4)
- Switzerland (8)
- Ukraine (1)
- United Kingdom (7)
- Europe
data types
Free Market Research Guides to Download
Pharmaceutical Analysis & Statistics in Europe Countries, May 2013
You might be interested in: therapeutics, cancer, drug, more »
» Purchase Premium Reports
1-30 of 36 reports
Orphan Drugs: Market Environment Products and Companies
- $ 1 566
- Industry report
- December 2012
- by Espicom Business Intelligence
The combination of government incentives to develop drugs for rare diseases and the promise of commercial opportunity will continue to fuel the industry's interest in orphan drugs; and provide hope to ...
- Industries : Drug and Medication
- Countries : United States, Australia, Japan, Sweden
The Pharmaceutical Market: Finland
- $ 1 313
- Industry report
- June 2012
- by Espicom Business Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
- Industries : Pharmaceutical
- Countries : Finland
The Pharmaceutical Market: Denmark
- $ 1 313
- Industry report
- June 2012
- by Espicom Business Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
- Industries : Pharmaceutical
- Countries : Denmark
The Pharmaceutical Market: Austria
- $ 1 313
- Industry report
- June 2012
- by Espicom Business Intelligence
Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens ...
- Industries : Pharmaceutical
- Countries : Austria
The Pharmaceutical Market: Norway
- $ 1 313
- Industry report
- June 2012
- by Espicom Business Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
- Industries : Pharmaceutical
- Countries : Norway
The Pharmaceutical Market: Belgium
- $ 1 313
- Industry report
- June 2012
- by Espicom Business Intelligence
Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens ...
- Industries : Pharmaceutical
- Countries : Belgium
The Pharmaceutical Market: UK
- $ 1 313
- Industry report
- June 2012
- by Espicom Business Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
- Industries : Pharmaceutical
- Countries : United Kingdom
Inhalation & Nasal Spray Generic Drugs 2012
- $ 1 969
- Industry report
- June 2012
- by Espicom Business Intelligence
It is no surprise then, that such high revenue originator drugs are attracting interest from prospective generic competitors. Unlike the oral generics market, however, where numerous companies typically ...
- Industries : Generic Drug
- Countries : United States, United Kingdom, Europe, World
Gedeon Richter Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Hungary
ratiopharm Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Germany, Canada, Europe, Netherlands, World, North America, United Kingdom
Stada Arzneimittel Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Germany
Krka Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Europe, Slovenia, Germany, World, China
Ranbaxy Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : South Africa, Canada, India, World, Africa, United States, Romania, Japan, Mexico, Malaysia, China, North America, Asia, Europe
Sanofi-Aventis Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Czech Republic, United Kingdom, Europe, Brazil, France, Germany, South America, World, Mexico, Slovakia (slovak Republic), Romania, Portugal
Actavis Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : United States, Europe, Iceland, Switzerland, Bulgaria, France, Germany, World, Netherlands, Norway, United Kingdom, Sweden, Spain, Russian Federation, Ireland, Austria, China, Serbia and Montenegro, North America
Egis Generics Company Intelligence Report
- $ 341
- Company report
- January 2011
- by Espicom Business Intelligence
Espicom's generics company reports will help you to understand the dynamic and complex issues affecting the business of leading generic industry players. These informative reports provide an insight into ...
- Industries : Generic Drug
- Countries : Hungary, Europe, Russian Federation, France, Austria, South Korea, World
Bayer: Pipeline - Products ? Performance - Potential
- $ 1 041
- Company report
- November 2010
- by Espicom Business Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...
- Industries : Over-the-counter Drug
- Countries : Germany
Multiple Sclerosis Drug Discoveries: what the future holds
- $ 2 266
- Industry report
- October 2010
- by Espicom Business Intelligence
EXTENSIVE ANALYSIS OF THE GLOBAL MULTIPLE SCLEROSIS MARKET AND ASSESSMENT OF ALL SIGNIFICANT CURRENT AND FUTURE PRODUCTS The recent approval in the US of Novartis' orally administered Gilenya (fingolimod) ...
- Industries : Drug Discovery and Development, Pathology
- Countries : World, Russian Federation
The Market forMedical Devices in Brazil, Russia, India & China
- $ 2 966
- Industry report
- October 2010
- by Espicom Business Intelligence
Evaluate the status, opportunities and threats for medical device companies in Brazil, Russia, India and China now and in the future. Includes market forecasts to 2014, plus free quarterly-updated market ...
- Industries : Pharmaceutical
- Countries : India, China, Russian Federation, Brazil
Epigenetics: Current and future applications that are driving novel drug discovery
- $ 1 218
- Industry report
- August 2010
- by Espicom Business Intelligence
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, ...
- Industries : Drug Discovery and Development, Genomics
- Countries : United States, Germany, Denmark, World, Canada
Lung Cancer: Global Incidence, Prevalence and Mortality to 2015
- $ 1 743
- Industry report
- July 2010
- by Espicom Business Intelligence
Lung cancer is expected to account for an estimated 12.5% of all new cancer cases in the leading economies in 2010, giving it the second highest incidence, marginally behind colorectal cancer and just ...
- Industries : Pathology, Healthcare
- Countries : Japan, United States, France, Spain, Germany, Italy, United Kingdom, World, Europe
Gilead Sciences: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- February 2010
- by Espicom Business Intelligence
Gilead's HIV product portfolio remains its strongest asset, generating 81.2 per cent of total company sales in 2008. Atripla and Truvada are expected have combined sales approaching US$5 billion by 2013, ...
- Industries : Drug and Medication, Pharmaceutical
- Countries : Ireland, United States
Gilead Sciences: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- February 2010
- by Espicom Business Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...
- Industries : Drug and Medication, Pharmaceutical
- Countries : Ireland, Japan
Alcon: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- February 2010
- by Espicom Business Intelligence
Alcon is a research and development-driven global company which develops, manufactures and markets pharmaceuticals, surgical equipment and devices, and consumer products to treat diseases and disorders ...
- Industries : Drug and Medication, Pharmaceutical
- Countries : Switzerland
Alcon: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- February 2010
- by Espicom Business Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...
- Industries : Drug and Medication, Medical Devices, Pharmaceutical
- Countries : Switzerland
UCB: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- January 2010
- by Espicom Business Intelligence
UCB is a global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of CNS disorders, allergy/respiratory ...
- Industries : Drug and Medication, Pharmaceutical
- Countries : Europe, South Korea, Belgium, World, Switzerland, United States, Spain, Italy, Germany, Japan, India
UCB: Pipeline - Products ? Performance - Potential
- $ 1 165
- Company report
- January 2010
- by Espicom Business Intelligence
Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...
- Industries : Biopharmaceutical, Pharmaceutical
- Countries : Europe, South Korea, Belgium, World, Switzerland, United States, Spain, Italy, Germany, Japan, India
AstraZeneca: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- October 2009
- by Espicom Business Intelligence
On 6th April 1999, AstraZeneca was formed through the merger of Astra AB of Sweden and Zeneca Group PLC of the UK, propelling the company to second in the world in terms of pharmaceutical sales. Since ...
- Industries : Drug and Medication, Pharmaceutical
- Countries : Sweden
Zentiva Generics Company Intelligence Report
- $ 343
- Company report
- October 2009
- by Espicom Business Intelligence
Zentiva was created through the merger of the Czech company, Léciva, and the Slovak firm Slovakofarma, which was completed in August 2003. The two former companies began selling products under the Zentiva ...
- Industries : Generic Drug
- Countries : Turkey, Slovakia (slovak Republic), Czech Republic, Europe, Lithuania, Ukraine, Russian Federation, Romania, Poland, Latvia, Bulgaria, World
Bayer: Pipeline - Products ? Performance - Potential
- $ 1 043
- Company report
- October 2009
- by Espicom Business Intelligence
Bayer is a global enterprise, headquartered in Germany, with core competencies in the fields of healthcare, nutrition and high-tech materials, and organised into three subgroups, namely HealthCare, CropScience ...
- Industries : Over-the-counter Drug, Pharmaceutical
- Countries : Germany
» Download Public Reports
About 4 000 reports
Company Report: Pathology in The United States and Ireland for Year 2013
- Company report
- May 2013
- 5 pages
- by Corporation
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
The French Pharmaceutical Industry Brief
April 2013Reportlinker.com © Copyright 2013. All rights reserved.
